Prarthana Rewatkar
- Molecular Biology
- Biomaterials top 5%
- Biomedical Engineering
- Pharmaceutical Science top 2%
- Organic Chemistry
- Co-authors
- Amirali PopatTushar KumeriaGanesh R. KokilHarendra S. ParekhZhi QuMarie‐Odile ParatSuresh TharejaTaskeen Iqbal Janjua
- Topics
- Advanced Drug Delivery Systems (6 papers)Synthesis and biological activity (4 papers)RNA Interference and Gene Delivery (4 papers)
In The Last Decade
Prarthana Rewatkar
23 papers receiving 852 citations
Peers
Comparison fields: 5 of 105
- Molecular Biology 364
- Biomaterials 191
- Biomedical Engineering 147
- Pharmaceutical Science 144
- Organic Chemistry 125
Countries citing papers authored by Prarthana Rewatkar
This map shows the geographic impact of Prarthana Rewatkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prarthana Rewatkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prarthana Rewatkar more than expected).
Fields of papers citing papers by Prarthana Rewatkar
This network shows the impact of papers produced by Prarthana Rewatkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prarthana Rewatkar. The network helps show where Prarthana Rewatkar may publish in the future.
Co-authorship network of co-authors of Prarthana Rewatkar
This figure shows the co-authorship network connecting the top 25 collaborators of Prarthana Rewatkar. A scholar is included among the top collaborators of Prarthana Rewatkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prarthana Rewatkar. Prarthana Rewatkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 15 | |
| 3 | 86 | |
| 4 | 47 | |
| 5 | 31 | |
| 6 | 180 | |
| 7 | 102 | |
| 8 | 38 | |
| 9 | 53 | |
| 10 | 44 | |
| 11 | 16 | |
| 12 | 57 | |
| 13 | QSAR Studies of Novel 1- and 8-Substituted-3-Furfuryl Xanthines: An Adenosine Receptor Antagonist | 3 |
| 14 | 33 | |
| 15 | 14 | |
| 16 | 8 | |
| 17 | 19 | |
| 18 | 6 | |
| 19 | Novel chromeneimidazole derivatives as antifungal compounds: synthesis and in vitro evaluation. | 43 |
| 20 | 31 |
About Prarthana Rewatkar
Prarthana Rewatkar is a scholar working on Pharmaceutical Science, Immunology and Allergy and Biomaterials, having authored 23 papers that have together received 867 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (6 papers), Synthesis and biological activity (4 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Pharmaceutical Science (144 citations), Biomaterials (191 citations) and Molecular Medicine (30 citations). Prarthana Rewatkar has collaborated with scholars based in Australia, India and Austria. Frequent co-authors include Amirali Popat, Tushar Kumeria, Ganesh R. Kokil, Harendra S. Parekh, Zhi Qu, Marie‐Odile Parat, Suresh Thareja, Taskeen Iqbal Janjua, Aria Ahmed-Cox and Friederike M. Mansfeld. Their work appears in journals such as PLoS ONE, Advanced Drug Delivery Reviews and Journal of Colloid and Interface Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.